Regeneron Pharmaceuticals, Inc.

UMB Bank, n.a. REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

1,060

Value ($000)

818

Weight

0.0%

2020 Q2 - 2025 Q4 (23 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	818	0.0%	1,060	12/31/2025
2025 Q3	11/4/2025	590	0.0%	1,049	9/30/2025
2025 Q2	7/11/2025	507	0.0%	965	6/30/2025
2025 Q1	4/14/2025	660	0.0%	1,041	3/31/2025
2024 Q4	1/16/2025	630	0.0%	884	12/31/2024
2024 Q3	10/9/2024	955	0.0%	908	9/30/2024
2024 Q2	7/29/2024	944	0.0%	898	6/30/2024
2024 Q1	4/26/2024	776	0.0%	806	3/31/2024
2023 Q4	1/23/2024	708	0.0%	806	12/31/2023
2023 Q3	10/18/2023	677	0.0%	823	9/30/2023
2023 Q2	7/25/2023	699	0.0%	973	6/30/2023
2023 Q1	4/11/2023	797	0.0%	970	3/31/2023
2022 Q4	1/10/2023	863	0.0%	1,196	12/31/2022
2022 Q3	10/13/2022	824	0.0%	1,196	9/30/2022
2022 Q2	7/20/2022	707	0.0%	1,197	6/30/2022
2022 Q1	4/22/2022	866	0.0%	1,240	3/31/2022
2021 Q4	2/9/2022	756	0.0%	1,197	12/31/2021
2021 Q3	10/18/2021	346	0.0%	572	9/30/2021
2021 Q2	7/26/2021	323	0.0%	578	6/30/2021
2021 Q1	4/15/2021	6,245	0.2%	13,199	3/31/2021
2020 Q4	2/4/2021	4,225	0.1%	8,744	12/31/2020
2020 Q3	10/16/2020	657	0.0%	1,053	9/30/2020
2020 Q2	7/16/2020	657	0.0%	1,053	6/30/2020